Company intelligence / Profile preview

Sophal

Ownership: Private
Development stage: Other

Overview

SOPHAL SPA is a biotechnology research company with 501–1,000 employees. The company specializes in biotechnology research and provides a unified portfolio of enterprise-grade omnichannel products through its Omnichannel Experience Management (OXM) platform. Further details about clinical results or specific therapeutic programs are not available from the provided sources[1].

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Sophal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sophal.

Explore the full profile